Your browser doesn't support javascript.
loading
Investigation of Clinical, Laboratory, Imaging Findings and Histopathological Features of Patients with Gastric Neuroendocrine Cell Hyperplasia.
Çoban, Burcu; Bengi, Göksel; Dervis Hakim, Gözde; Mehtat Ünlü, Sadiye; Solakoglu Kahraman, Dudu; Barlik, Funda; Çapa Kaya, Gamze; Soytürk, Müjde.
Afiliación
  • Çoban B; Division of Internal Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Bengi G; Division of Internal Medicine, Department of Gastroenterology, Dokuz Eylül University, Izmir, Turkey.
  • Dervis Hakim G; Division of Gastroenterology, Department of Internal Medicine, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Mehtat Ünlü S; Department of Pathology, Dokuz Eylül University, Izmir, Turkey.
  • Solakoglu Kahraman D; Department of Pathology, Health Sciences University, Izmir Faculty of Medicine, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Barlik F; Department of Radiology, Dokuz Eylül University, Izmir, Turkey.
  • Çapa Kaya G; Department of Nuclear Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Soytürk M; Division of Internal Medicine, Department of Gastroenterology, Dokuz Eylül University, Izmir, Turkey.
Turk J Gastroenterol ; 35(2): 92-101, 2024 02.
Article en En | MEDLINE | ID: mdl-38454240
ABSTRACT
BACKGROUND/

AIMS:

Neuroendocrine cell hyperplasia is a non-neoplastic proliferation of enterochromaffin-like cells and is considered a premalignant lesion because of their potential to progress to neuroendocrine tumor. In this study, we aimed to evaluate the demographic and clinical features, laboratory, radiological and endoscopic findings, gastric biopsy histopathological features, follow-up frequency, and histopathological findings of patients diagnosed with gastric neuroendocrine cell hyperplasia as well as to investigate the factors that play a role in the development of neuroendocrine tumors on the basis of neuroendocrine cell hyperplasia. MATERIALS AND

METHODS:

The study has been conducted in 2 centers with 282 patients that were grouped as those with and without neuroendocrine tumor. Individuals with control endoscopy were separated as those with regression of neuroendocrine cell hyperplasia and those without regression, and the determined parameters were evaluated between the groups.

RESULTS:

The most common histological subtype of neuroendocrine cell hyperplasia was linear+micronodular (50.4%). Neuroendocrine tumor developed in 4.3% (12/282) of the patients with neuroendocrine cell hyperplasia after a mean of 36 months. The presence of polyps as confirmed via endoscopy and dysplasia as confirmed via histopathological examination was significantly higher in favor of the group with neuroendocrine tumor (P = .01). In patients with neuroendocrine cell hyperplasia regressed and patients in whom it did not regress were examined, the rate of asymptomatic patients and increased sedimentation rate were found in favor of the group that did not regress (P = .02 and P = .02), but no difference was found in other parameters.

CONCLUSION:

Neuroendocrine tumor development rate was found to be 4.3% in the background of neuroendocrine cell hyperplasia. Two factors predicting progression from neuroendocrine cell hyperplasia to neuroendocrine tumor can be elaborated as the presence of polypoid appearance due to neuroendocrine cell hyperplasia as confirmed via endoscopy and dysplasia as confirmed via histopathological examination.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pólipos / Neoplasias Gástricas / Tumores Neuroendocrinos / Células Neuroendocrinas Límite: Humans Idioma: En Revista: Turk J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pólipos / Neoplasias Gástricas / Tumores Neuroendocrinos / Células Neuroendocrinas Límite: Humans Idioma: En Revista: Turk J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Turquía